Dr. med. Olaf Schmidt

Facharzt für Innere Medizin, Schwerpunkt Pneumologie

Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease; R Aalbers, MR Maleki-Yazdi, A Hamilton, S Waitere-Wijker, Y Zhao, VC Amatto, O Schmidt, L Bjermer; Adv Ther. 2015 Sep;32(9):809-22. Adv Ther (2015) 32:809-822

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life; D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallmann, N Bennett, R Abrahams, O Schmidt, L Bjermer; Respir Med. 2015 Oct;109(10):1312-9

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials; HAM Kerstjens, TB Casale, ER Bleecker, EO Meltzer, E Pizzichini, O Schmidt, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf, ED Bateman; Lancet Respir Med. 2015;3(5):367-376

Anforderungen an die moderne Inhalationstherapie; O. Schmidt; Medizin Report aktuell Nr. 411166 in: PneumoNews 1/2015

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO studies; D Singh, M Gaga, O Schmidt, L Bjermer, L Grönke, F Voß, GT Ferguson; Respiratory Research. 2016 Jun; 17:73

Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler e Results from a non-interventional study; O. Schmidt , W. Petro , G. Hoheisel , F. Kanniess , P. Oepen , B. Langer-Brauburger; Respiratory Medicine 131 (2017) 166e174

Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma; Christian Vogelberg, Michael Engel, István Laki, Jonathan A. Bernstein, Olaf Schmidt, Georges El Azzi, Petra Moroni-Zentgraf, Ralf Sigmund and Eckard Hamelmann; The Journal of Allergy an Clinical Immunology / In Practice / 2018

Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD; R Aalbers, RM Maleki-Yazdi, A Hamilton, S Waitere-Wijker, A Pivovarova, O Schmidt, L Bjermer;
European Respiratory Society (ERS) – International Congress 2012

Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses; TB Casale, ER Bleecker, E Meltzer, E Pizzichini, O Schmidt, ED Bateman, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf, HAM Kerstjens;
European Academy of Allergy and Clinical Immunology (EAACI) – International Congress 2013

Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: lung function and safety;
HAM Kerstjens, ER Bleecker, E Meltzer, TB Casale, E Pizzichini, O Schmidt, ED Bateman, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf;
European Respiratory Society (ERS) – International Congress 2013
Thoracic Society of Australia and New Zealand (TSANZ) – International Congress 2014
Congrès de pneumologie de langue française (CPLF) – International Congress 2014
Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP) – Kongress der DGP 2014

Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate;
HAM Kerstjens, E Bleecker, E Meltzer, TB Casale, E Pizzichini, O Schmidt, M Engel, LJ Bour, CB Verkjeij, P Moroni-Zentgraf, ED Bateman;
European Respiratory Society (ERS) – International Congress 2013
Thoracic Society of Australia and New Zealand (TSANZ) – International Congress 2014
Congrès de pneumologie de langue française (CPLF) – International Congress 2014
Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP) – Kongress der DGP 2014

Asthmabehandlung mit Fluticasonpropionat / Formoterol-Kombination: Zwischenergebnisse einer nicht-interventionellen Studie zur Sicherheit und Wirksamkeit; O Schmidt, F Kanniess, B Langer-Brauburger; Kongress der DGP 2015

FLT9501 ffairness – Studie; flutiform; eine neue Wirkstoffkombination zur Asthmabehandlung nicht- interventionelle Studie zur Sicherheit und Wirksamkeit Ergebnisse Interimsanalyse II; O Schmidt; Kongress der DGP 2015

Once-daily tiotropium Respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma; Schmidt O, Halpin D, Bateman E, Paggiaro P, Bleecker E, Engel M, Moroni-Zentgraf P, Schmidt H, Kerstjens H; Posterbeitrag Kongress der DGP 2015

Once-daily tiotropium Respimat add-on to ICS±LABA improves control across asthma severities; O Schmidt, M FitzGerald, H Kerstjens, P Paggiaro, K Ohta, M Ichinose, P Moroni-Zentgraf, M Engel, H Schmidt, ED Bateman; Posterbeitrag Kongress der DGP 2015

Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in patients with symptomatic asthma in Japan receiving ICS ± LABAs: a randomized, double-blind, placebo-controlled study; O Schmidt, K Ohta, M Ichinose, Y Tohda, M Engel, P Moroni-Zentgraf, S Kunimitsu, W Sakamoto, M Adachi; Posterbeitrag Kongress der DGP 2015

Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallmann, N Bennett, R Abrahams, O Schmidt, L Bjermer;
European Respiratory Society (ERS) – International Congress 2015
Canadian Thoracic Society (CTS) – International Congress 2016

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life versus placebo
D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallman, N Bennett, R Abrahams, O Schmidt, L Bjermer;
The International Primary Care Respiratory Group (IPCRG) – International Congress 2016

Fluticasone propionate/formoterol therapy for asthmatic patients: results of a non-interventional study
O. Schmidt, F. Kanniess, P. Oepen, B. Langer-Brauburger; European Respiratory Society (ERS) – International Congress 2016

Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma
Olaf Schmidt, Eckard Hamelmann, Christian Vogelberg, István Laki, Georges El Azzi, Michael Engel, Petra Moroni-Zentgraf, Helen Finnigan, Mark Vandewalker; European Respiratory Society (ERS) – International Congress 2016

Amélioration cliniquement pertinente de la qualité de vie avec l’association fixe tiotropium + olodaterol versus placebo chez les patients BPCO; P Berger, D Singh, GT Ferguson, J Bolitschek, L Grönke, R Abrahams, O Schmidt, L Bjermer;
Congrès de pneumologie de langue française (CPLF) – International Congress 2016

Safety and tolerability of once-daily tiotropium Respimat add-on therapy in children with moderate symptomatic asthma
Christian Vogelberg, István Laki, Olaf Schmidt, Eckard Hamelmann, Georges El Azzi, Michael Engel, Petra Moroni-Zentgraf, Helen Finnigan, Mark Vandewalker; European Respiratory Society (ERS) – International Congress 2016

Pooled analysis of the efficacy and safety from two non-interventional studies of fluticasone propionate/formoterol pMDI
Vibeke Backer, Olaf Schmidt, Birgit Langer-Brauburger, Tanja Schmidt, Carla Bennett, Dirk Lindner, Susanna Cuadripani, Birgit Grothe, Tim Overend; European Respiratory Society (ERS) – International Congress 2018

Therapie des schweren Asthmas – eine Frage der Präzision: Eine Orientierung aus Theorie und Praxis; Moderne Präzisionstherapie – die Perspektive aus der Praxis – Interaktive Falldiskussionen; O Schmidt, Koblenz; Präsentation Kongress der DGP 2019

Short-Term and Maintenance Oral Corticosteroid Use for German Patients with Asthma; Cassandra Nan, Robert Lindner, Yasemin Ilgin, Thomas Schultz, Olaf Schmidt, Lykke Hinsch Gylvin, Eugene R. Bleecker; European Respiratory Society (ERS) – International Congress 2019